Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads
- PMID: 19778015
- PMCID: PMC2761975
- DOI: 10.1021/ja9071282
Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads
Erratum in
- J Am Chem Soc. 2010 Dec 8;132(48):17335
- J Am Chem Soc. 2010 Mar 3;132(8):2845
Abstract
Amine-functionalized polyvalent oligonucleotide gold nanoparticles (DNA-Au NPs) were derivatized with a cisplatin prodrug, and the resulting DNA-Au NP conjugates were used to internalize multiple platinum centers. A platinum(IV) complex, c,c,t-[Pt(NH(3))(2)Cl(2)(OH)(O(2)CCH(2)CH(2)CO(2)H)], was tethered to the surface of DNA-Au NPs through amide linkages. The platinum-tethered gold nanoparticles were taken into several cancer cells. The drop in intracellular pH facilitated reductive release of cisplatin from the prodrug, which then formed 1,2-d(GpG) intrastrand cross-links in the cell nuclei, as confirmed by an antibody specific for this adduct. The cytotoxicity of the platinum(IV) complex increases significantly in several cancer cell lines when the complex is attached to the surface of the DNA-Au NPs and in some instances exceeds that of cisplatin.
Figures
), cisplatin (■), 1 (
) with U2OS, A549, HeLa, and PC3 cells.
References
-
- Jamieson ER, Lippard SJ. Chem Rev. 1999;99:2467–2498. - PubMed
-
- Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Nature. 1969;222:385–6. - PubMed
-
- Galanski M, Jakupec MA, Keppler BK. Curr Med Chem. 2005;12:2075–2094. - PubMed
-
- Hartmann JT, Kollmannsberger C, Kanz L, Bokemeyer C. Int J Cancer. 1999;83:866–9. - PubMed
-
- Laurell G, Jungnelius U. Laryngoscope. 1990;100:724–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
